NGeneBio exhibited at the Korean Society of Pathology Autumn Conference, held at The-K Seoul Hotel's Gaya Hall from November 2 to November 4, 2022.

During this autumn conference, NGeneBio showcased its solid cancer precision diagnostic product, ONCOaccuPanel™, which has been commercialized following technology transfer from the Asan Medical Center. The company is now expanding its presence in both domestic and international markets.

This event provided a valuable opportunity for NGeneBio to emphasize its innovative technologies and product strengths, thereby enhancing brand awareness. Building on this foundation, NGeneBio aims to further expand the adoption of NGS-based precision diagnostic products in medical institutions.